| 臺大學術典藏 |
2018-09-10T03:42:13Z |
Lung abscesses: US examination and US-guided transthoracic aspiration
|
Yang, P.-C. and Luh, K.-T. and Lee, Y.-C. and Chang, D.-B. and Yu, C.-J. and Wu, H.-D. and Lee, L.-N. and Kuo, S.-H.; LI-NA LEE |
| 臺大學術典藏 |
2021-03-12T02:29:14Z |
Lung abscesses: US examination and US-guided transthoracic aspiration
|
Yang P.-C.;Luh K.-T.;Lee Y.-C.;Chang D.-B.;Yu C.-J.;Wu H.-D.;Li-Na Lee;Kuo S.-H.; Yang P.-C.; Luh K.-T.; Lee Y.-C.; Chang D.-B.; Yu C.-J.; Wu H.-D.; LI-NA LEE; Kuo S.-H. |
| 國立臺灣大學 |
1991-02 |
Lung Abscesses:US Examination and US-Guided Transthoracic Aspiration
|
楊泮池; Luh, Kwen-Tay; Lee, Yung-Chie; Chang, Dun-Bing; Yu, Chong-Jen; Wu, Huey-Dong; Lee, Li-Na; 郭壽雄; Yang, Pan-Chyr; Luh, Kwen-Tay; Lee, Yung-Chie; Chang, Dun-Bing; Yu, Chong-Jen; Wu, Huey-Dong; Lee, Li-Na; Kuo, Sow-Hsong |
| 國家衛生研究院 |
2004-09-15 |
Lung adenocarcinoma and human papillomavirus infection
|
Chen, YC; Chen, JH; Richard, K; Chen, PY; Christiani, DC |
| 國立臺灣大學 |
2004 |
Lung Adenocarcinoma and Human Papillomavirus Infection
|
程蘊菁; 陳人豪; 陳柏仰; CHEN, YEN-CHING; CHEN, JEN-HAU; CHEN, PAO-YANG |
| 臺大學術典藏 |
2018-09-10T05:01:15Z |
Lung adenocarcinoma and human papillomavirus infection
|
Chen, Y.-C.;Chen, J.-H.;Richard, K.;Chen, P.-Y.;Christiani, D.C.; YEN-CHING CHEN |
| 臺大學術典藏 |
2020-11-30T07:35:55Z |
Lung adenocarcinoma and human papillomavirus infection
|
Chen Y.-C.;Jen-Hau Chen;Richard K.;Chen P.-Y.;Christiani D.C.; Chen Y.-C.; JEN-HAU CHEN; Richard K.; Chen P.-Y.; Christiani D.C. |
| 臺大學術典藏 |
2022-05-09T08:46:49Z |
Lung adenocarcinoma and human papillomavirus infection
|
YEN-CHING CHEN; Chen J.-H.; Richard K.; Chen P.-Y.; Christiani D.C. |
| 臺北醫學大學 |
2015-12 |
lung adenocarcinoma of Iressa
|
曾怡文 |
| 臺大學術典藏 |
2018-09-10T18:04:09Z |
Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors
|
Wu, S.-G. and Chang, Y.-L. and Yu, C.-J. and Yang, P.-C. and Shih, J.-Y.; YIH-LEONG CHANG; Chong-Jen Yu; JIN-YUAN SHIH |
| 臺大學術典藏 |
2017 |
Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors
|
Wu S.-G.;Yih-Leong Chang;Yu C.-J.;Yang P.-C.;Shih J.-Y.; Wu S.-G.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-06T05:26:05Z |
Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors
|
Wu S.-G.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2022-06-27T07:00:08Z |
Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors
|
Wu S.-G.; Chang Y.-L.; CHONG-JEN YU; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2022-09-08T08:16:43Z |
Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors
|
Wu, Shang-Gin; Chang, Yih-Leong; Yu, Chong-Jen; PAN-CHYR YANG; Shih, Jin-Yuan |
| 國立臺灣大學 |
2008 |
Lung Adenocarcinoma with Good Response to Erlotinib after Gefitinib Treatment Failure and Acquired T790m Mutation
|
吳尚俊; 施金元; 余忠仁; 楊泮池; WU, SHANG-GIN; SHIH, JIN-YUAN; YU, CHONG-JEN; YANG, PAN-CHYR |
| 臺大學術典藏 |
2018-09-10T06:47:49Z |
Lung adenocarcinoma with good response to erlotinib after gefitinib treatment failure and acquired T790M mutation
|
Wu, S.-G. and Shih, J.-Y. and Yu, C.-J. and Yang, P.-C.; Chong-Jen Yu; JIN-YUAN SHIH |
| 臺大學術典藏 |
2008 |
Lung adenocarcinoma with good response to erlotinib after gefitinib treatment failure and acquired T790M mutation
|
Yang P.-C.; Yu C.-J.; JIN-YUAN SHIH; Wu S.-G. |
| 臺大學術典藏 |
2020-08-12T08:25:32Z |
Lung adenocarcinoma with good response to erlotinib after gefitinib treatment failure and acquired T790M mutation
|
SHANG-GIN WU; Shih J.-Y.; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2020-12-02T02:34:38Z |
Lung adenocarcinoma with good response to erlotinib after gefitinib treatment failure and acquired T790M mutation
|
Wu S.-G.;Shih J.-Y.;Yu C.-J.;Pan-Chyr Yang; Wu S.-G.; Shih J.-Y.; Yu C.-J.; PAN-CHYR YANG |
| 臺大學術典藏 |
2022-06-27T07:06:27Z |
Lung adenocarcinoma with good response to erlotinib after gefitinib treatment failure and acquired T790M mutation
|
Wu S.-G.; Shih J.-Y.; CHONG-JEN YU; Yang P.-C. |
| 臺大學術典藏 |
2018-09-10T18:05:21Z |
Lung adenocarcinoma with intraoperatively diagnosed pleural seeding: Is main tumor resection beneficial for prognosis?
|
Li, C. and Kuo, S.-W. and Hsu, H.-H. and Lin, M.-W. and Chen, J.-S.; SHUENN-WEN KUO; HSAO-HSUN HSU; JIN-SHING CHEN |
| 臺大學術典藏 |
2020-03-30T08:50:52Z |
Lung adenocarcinoma with intraoperatively diagnosed pleural seeding: Is main tumor resection beneficial for prognosis?
|
Li C.;Kuo S.-W.;Hsu H.-H.;Lin M.-W.;Jin-Shing Chen; Li C.; Kuo S.-W.; Hsu H.-H.; Lin M.-W.; JIN-SHING CHEN |
| 臺大學術典藏 |
2020-05-18T08:38:53Z |
Lung adenocarcinoma with intraoperatively diagnosed pleural seeding: Is main tumor resection beneficial for prognosis?
|
Li C.;Shuenn-Wen Kuo;Hsu H.-H.;Lin M.-W.;Chen J.-S.; Li C.; SHUENN-WEN KUO; Hsu H.-H.; Lin M.-W.; Chen J.-S. |
| 臺大學術典藏 |
2021-05-24T03:41:44Z |
Lung adenocarcinoma with intraoperatively diagnosed pleural seeding: Is main tumor resection beneficial for prognosis?
|
Li C.; Kuo S.-W.; HSAO-HSUN HSU; Lin M.-W.; Chen J.-S. |
| 臺大學術典藏 |
2021-10-08T08:16:24Z |
Lung adenocarcinoma with intraoperatively diagnosed pleural seeding: Is main tumor resection beneficial for prognosis?
|
Li C.; Kuo S.-W.; Hsu H.-H.; MONG-WEI LIN; Chen J.-S. |
